Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Gut

• Publication date

  2009-01-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/gut.2008.170019PMID 19136508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory bowel disease.

  2011cited by this paper
• How dying cells alert the immune system to danger

  2008influential reference
• Medical management of Crohn’s disease

  2008cited by this paper
• Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

  2008cited by this paper
• Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases

  2008cited by this paper
• Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti‐TNF‐alpha therapy for Crohn's disease

  2008cited by this paper
• Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

  2008cited by this paper
• Phagocyte‐specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease

  2008cited by this paper
• Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

  2008cited by this paper
• Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

  2008cited by this paper
• Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

  2008cited by this paper
• Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases

  2008cited by this paper
• Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?

  2008cited by this paper
• Faecal S 100 A 12 as a non-invasivemarker distinguishing inflammatory bowel disease from irritable bowel syndrome

  2008cited by this paper
• Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.

  2008cited by this paper
• Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy

  2007cited by this paper
• Fecal Calprotectin in First-Degree Relatives of Patients with Ulcerative Colitis

  2007cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Medical Management of Crohn's Disease

  2007cited by this paper
• Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

  2007cited by this paper
• Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

  2007influential reference
• Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome

  2007cited by this paper
• Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel Disease

  2007cited by this paper
• Prospective evaluation of faecal neutrophil‐derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin

  2007cited by this paper
• Cooperation of Toll-like receptor signals in innate immune defence

  2007cited by this paper
• DAMPs, PAMPs and alarmins: all we need to know about danger

  2007cited by this paper
• S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules

  2007cited by this paper
• Fecal Calprotectin in Very Low Birth Weight Infants

  2007cited by this paper
• Mechanisms of Disease: a 'DAMP' view of inflammatory arthritis

  2007cited by this paper
• Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis

  2007cited by this paper
• Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

  2007cited by this paper
• Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

  2007cited by this paper
• Time course of faecal calprotectin in preterm newborns during the first month of life

  2007cited by this paper
• Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.

  2006cited by this paper
• Fecal S100A12: A novel noninvasive marker in children with Crohn's disease

  2006cited by this paper
• Laboratory markers in IBD: useful, magic, or unnecessary toys?

  2006cited by this paper
• CARD15/NOD2 Mutations in Crohn's Disease

  2006cited by this paper
• Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis

  2006cited by this paper
• Intracellular pattern recognition receptors in the host response

  2006cited by this paper
• Carboxylated Glycans Mediate Colitis through Activation of NF-κB1

  2005cited by this paper
• Lactoferrin

  2005cited by this paper
• Comparison of 4 Neutrophil‐Derived Proteins in Feces As Indicators of Disease Activity in Ulcerative Colitis

  2005cited by this paper
• Carboxylated glycans mediate colitis through activation of NF-kappa B.

  2005cited by this paper
• Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease

  2005cited by this paper
• Colorectal Inflammation is Well Predicted by Fecal Calprotectin in Children with Gastrointestinal Symptoms

  2005cited by this paper
• Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells.

  2005cited by this paper
• High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

  2005cited by this paper
• Proinflammatory S100 proteins in arthritis and autoimmune disease.

  2004cited by this paper
• Bowel Inflammation as Measured by Fecal Calprotectin

  2004cited by this paper
• Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers

  2004cited by this paper
• Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology

  2004cited by this paper
• Therapeutics targeting the innate immune system

  2004cited by this paper
• Fecal α1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum

  2003cited by this paper
• Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?

  2003cited by this paper
• Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing.

  2003cited by this paper
• NALPs: a novel protein family involved in inflammation

  2003cited by this paper
• Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children.

  2003cited by this paper
• Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis.

  2003cited by this paper
• Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

  2003cited by this paper
• Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules.

  2003cited by this paper
• Inflammatory bowel disease.

  2002cited by this paper
• Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children

  2002cited by this paper
• Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.

  2002cited by this paper
• S100 proteins: structure, functions and pathology.

  2002cited by this paper
• Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance

  2002cited by this paper
• Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study.

  2002cited by this paper
• Lactoferrin and host defense.

  2002cited by this paper
• A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease

  2002cited by this paper
• The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

  2001cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• Molecular cloning and functional expression of a human intestinal lactoferrin receptor.

  2001cited by this paper
• The Ca2+-binding Proteins S100A8 and S100A9 Are Encoded by Novel Injury-regulated Genes*

  2001cited by this paper
• Established and emerging biological activity markers of inflammatory bowel disease.

  2000cited by this paper
• Clinical Reviews

  2000cited by this paper
• A simple method for assessing intestinal inflammation in Crohn's disease

  2000cited by this paper
• Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

  2000cited by this paper
• Innate immunity.

  2000cited by this paper
• Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy

  2000cited by this paper
• Faecal parameters in the assessment of activity in inflammatory bowel disease.

  1999cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999influential reference
• Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease

  1999cited by this paper
• Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease

  1999cited by this paper
• Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.

  1999cited by this paper
• Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.

  1999cited by this paper
• S100A12 Is Expressed Exclusively by Granulocytes and Acts Independently from MRP8 and MRP14*

  1999cited by this paper
• Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis

  1999cited by this paper
• The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils.

  1998cited by this paper
• Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.

  1997cited by this paper
• Myeloid-related Protein (MRP) 8 and MRP14, Calcium-binding Proteins of the S100 Family, Are Secreted by Activated Monocytes via a Novel, Tubulin-dependent Pathway*

  1997cited by this paper
• Mapping of a susceptibility locus for Crohn's disease on chromosome 16

  1996cited by this paper
• Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.

  1996cited by this paper
• Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.

  1996cited by this paper
• Innate immunity.

  1996cited by this paper
• Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease.

  1995cited by this paper
• Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases.

  1995cited by this paper
• Lactoferrin: a general review.

  1995cited by this paper
• Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.

  1995cited by this paper
• Immunochemical detection of human lactoferrin in feces as a new marker for inflammatory gastrointestinal disorders and colon cancer.

  1994cited by this paper
• Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.

  1993cited by this paper
• Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.

  1993cited by this paper

• Deployment of a cloud-based passive defecation monitoring system for continuous gut health monitoring.

  2026cites this paper
• Serum calprotectin correlates with severity of severe fever with thrombocytopenia syndrome

  2025cites this paper
• Optimal positioning of biomarkers according to ulcerative colitis activity

  2025cites this paper
• Differential Diagnosis Value of Neutrophil Gelatinase Associated Lipocalin as a Noninvasive Biomarker in Perianal Fistulizing Crohn’s Disease

  2025cites this paper
• Research progress on the diagnostic value of fecal calprotectin in colorectal tumors

  2025cites this paper
• Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily Practice

  2025cites this paper
• Anti-Bacterial and Anti-Inflammatory Properties of Sophoridine and Its Effect on Diarrhea in Mice

  2025cites this paper
• Reference intervals for equine fecal calprotectin and calprotectin:protein ratio and preliminary clinical evaluation in horses with colic and colitis.

  2024cites this paper
• A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General Population

  2024cites this paper
• A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome

  2024cites this paper
• Hepatotoxicity assessment of innovative nutritional supplements based on olive-oil formulations enriched with natural antioxidants

  2024cites this paper
• Systematic evaluation supports the use of ELISA for quantification of calprotectin in equine feces, a first step toward noninvasive quantification of intestinal inflammation in horses.

  2024cites this paper
• Fecal calgranulin as a potential screening tool to differentiate inflammatory bowel disease from irritable bowel syndrome

  2024cites this paper
• Efficacy of sequential fecal-marker examination for evaluating gastrointestinal inflammation in solid food protein-induced enterocolitis syndrome.

  2024cites this paper
• Transcriptional Profiles of Non-neuronal and Immune Cells in Mouse Trigeminal Ganglia

  2023cites this paper
• Transcriptional profiles of non-neuronal and immune cells in mouse trigeminal ganglia

  2023cites this paper
• An IoT-based Smart Bathroom for Healthy Life

  2023cites this paper
• Autoimmune pancreatitis associated with inflammatory bowel diseases: A retrospectively bidirectional case–control study in China

  2023cites this paper
• Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems

  2023cites this paper
• Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer

  2023cites this paper
• Plasma Calprotectin Levels Associate With New‐Onset Hypertension in the General Population: A Prospective Cohort Study

  2023cites this paper
• Proposed morbidity markers among Schistosoma mansoni patients

  2023cites this paper
• Evaluation of fecal Activin-A as a novel biomarker for early diagnosis of ulcerative colitis using experimental murine animal model.

  2023cites this paper
• IS FECAL CALPROTECTIN DETERMINATION USEFUL FOR PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE?

  2023cites this paper
• Influence of Perinatal Factors on Blood Tryptase and Fecal Calprotectin Levels in Newborns

  2023influential citation
• Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?

  2022cites this paper
• Advances in the Treatment of Inflammatory Bowel Disease: Focus on Polysaccharide Nanoparticulate Drug Delivery Systems.

  2022cites this paper
• Emerging role of colorectal mucus in gastroenterology diagnostics

  2022cites this paper
• Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population

  2022cites this paper
• Factors associated with anaemia among preschool- age children in underprivileged neighbourhoods in Antananarivo, Madagascar

  2022cites this paper
• Ubiquitin-modifying enzymes as regulators of colitis.

  2022cites this paper
• Comparative Analysis between Urinary Calprotectin and Serum Creatinine for Early Detection of Intrinsic Acute Kidney Injury

  2021cites this paper
• Fecal Calprotectin Level in Term and Preterm Babies before and after Starting of Feeding

  2021cites this paper
• A Cross-Sectional and Longitudinal Study to Define Alarmins and A-SAA Variants as Companion Markers in Early Rheumatoid Arthritis

  2021cites this paper
• Faecal Inflammatory Biomarkers and Gastrointestinal Symptoms after Bariatric Surgery: A Longitudinal Study

  2021cites this paper
• Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis

  2021cites this paper
• Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study

  2021cites this paper
• DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod

  2021influential citation
• Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania

  2021cites this paper
• Фенотипический профиль лимфоидных клеток периферической крови пациентов с воспалительными заболеваниями кишечника

  2021influential citation
• DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod

  2021cites this paper
• S100A8 and S100A9 are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.

  2020cites this paper
• RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND OTHER IMMUNOLOGICAL PARAMETERS IN DIARRHEAL CHILDREN INFECTED WITH ENTAMOEBA HISTOLYTICA AND PATHOGENIC BACTERIA IN THI-QAR PROVINCE, IRAQ

  2020cites this paper
• Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity

  2020cites this paper
• Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps

  2020cites this paper
• Spontaneous onset of TNFα‐triggered colonic inflammation depends on functional T lymphocytes, S100A8/A9 alarmins, and MHC H‐2 haplotype

  2020cites this paper
• Biomarkers of irritable bowel syndrome

  2020cites this paper
• Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.

  2020cites this paper
• Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease

  2019cites this paper
• Serum calprotectin as a predictive biomarker in the treatment of psoriasis vulgaris with methotrexate

  2019cites this paper
• Differential Expression of Soluble Receptor for Advanced Glycation End-products in Mice Susceptible or Resistant to Chronic Colitis

  2019cites this paper
• Phenotype of histologically suspected drug-induced colitis; results of a comparative, retrospective cohort study

  2019cites this paper
• Differential expression of soluble receptor for advanced glycation end-products (sRAGE) in mice susceptible or resistant to chronic colitis

  2019cites this paper
• Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease.

  2019cites this paper
• PREVALENCE OF INTESTINAL PROTOZOA AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME

  2019cites this paper
• A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.

  2019cites this paper
• Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy

  2019cites this paper
• Analytical validation of an enzyme-linked immunosorbent assay for the quantification of S100A12 in the serum and feces of cats.

  2019cites this paper
• Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study.

  2019cites this paper
• The Role of Biomarkers in Treatment Algorithms for Ulcerative Colitis (UC)

  2019cites this paper
• Fecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review.

  2019cites this paper
• Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.

  2019cites this paper
• Enfermedad inflamatoria intestinal: aspectos prácticos para el médico de familia

  2019cites this paper
• Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures

  2019cites this paper
• Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs

  2018cites this paper
• Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.

  2018cites this paper
• Estudi transcripcional de la Colitis Ulcerosa. Caracterització i cerca de biomarcadors

  2018cites this paper
• Effect of selected gastrointestinal parasites and viral agents on fecal S100A12 concentrations in puppies as a potential comparative model

  2018cites this paper
• Early life programming of piglets' microbiota and gut health by maternal dietary fibre supplementation

  2018cites this paper
• Fecal calprotectin reflects endoscopic activity in patients with small-bowel Crohn’s disease according to double-balloon endoscopy findings

  2018cites this paper
• Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission

  2018cites this paper
• Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests

  2018cites this paper
• University of Groningen Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines Bourgonje,

  2018cites this paper
• Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines

  2018cites this paper
• Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease

  2018cites this paper
• Paediatric schistosomiasis: What we know and what we need to know

  2018cites this paper
• Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal

  2018cites this paper
• The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.

  2018cites this paper
• S100-alarmins: potential therapeutic targets for arthritis

  2017cites this paper
• Patient-relevant outcomes of stool testing in pediatric inflammatory bowel disease

  2017cites this paper
• A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis

  2017cites this paper
• PATIENT-RELEVANT OUTCOMES OF STOOL TESTING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

  2017cites this paper
• Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease

  2017cites this paper
• Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.

  2017cites this paper
• Luminally expressed gastrointestinal biomarkers

  2017cites this paper
• Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders

  2017cites this paper
• IBD immunopathogenesis: A comprehensive review of inflammatory molecules.

  2017cites this paper
• Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization

  2017cites this paper
• SELECTING CHILDREN SUSPECTED OF IBD FOR ENDOSCOPY

  2017cites this paper
• Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study

  2017cites this paper
• Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.

  2017cites this paper
• Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen

  2017cites this paper
• Inflammatory bowel disease detection and monitoring by measuring biomarkers in non‐invasively collected colorectal mucus

  2017cites this paper
• Evaluation of Fecal Pyruvatekinase Isoenzyme (M2-PK) Level in Differentiating Functional from Organic Colonic Disorders = تقييم دور معدل مشتقات البيروفات كيناز في البراز في التمييز بين أمراض القولون الوظيفية والعضوية

  2017cites this paper
• Fecal calprotectin among patients infected with some protozoan infections

  2017cites this paper
• Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents

  2017cites this paper
• Calprotectin in rheumatic diseases

  2017cites this paper
• Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome

  2017cites this paper
• Metaproteomics of colonic microbiota unveils discrete protein functions among colitic mice and control groups

  2017cites this paper
• Fecal neutrophil gelatinase‐associated lipocalin as a biomarker for inflammatory bowel disease

  2017cites this paper